Cargando...
Association between immunosuppressive therapy and course of mild interstitial lung disease in systemic sclerosis
OBJECTIVE: Interstitial lung disease (ILD) is a leading cause of mortality in SSc. Little is known about the benefits of immunosuppressive drugs in mild ILD. Our aim was to determine whether use of CYC or MMF was associated with an improved ILD course in patients with normal or mildly impaired lung...
Gardado en:
| Publicado en: | Rheumatology (Oxford) |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Oxford University Press
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7850061/ https://ncbi.nlm.nih.gov/pubmed/31535689 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kez407 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|